Medical Xpress October 22, 2024
Overall, cancer detection in the United States recovered meaningfully in 2021 following substantial disruptions in 2020, according to a study published online Oct. 14 in JAMA Network Open.
Uriel Kim, M.D., Ph.D., from the Cedars-Sinai Medical Center in Los Angeles, and colleagues evaluated the disruption and potential recovery in cancer detection during the first (2020) and second (2021) years of the COVID-19 pandemic. The analysis included data on roughly 15.8 million patients with incident cancer (2000 through 2021) identified from the Surveillance, Epidemiology, and End Results Program.
The researchers found that the percentage difference between the expected and observed cancer incidence in 2020 was −8.6%,...